196
Views
11
CrossRef citations to date
0
Altmetric
Review

Management of bacterial infections in children with asthma

Pages 869-877 | Published online: 10 Jan 2014

References

  • Morgan WJ, Stern DA, Sherrill DL et al. Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence. Am. J. Respir. Crit. Care Med.172, 1253–1258 (2005).
  • Stern DA, Morgan WJ, Halonen M, Wright AL, Martinez FD. Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet372, 1058–1064 (2008).
  • Jartti T, Lehtinen P, Vuorinen T et al. Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerg. Infect. Dis.10, 1095–1101 (2004).
  • Allander T, Jartti T, Gupta S et al. Human bocavirus and acute wheezing in children. Clin. Infect. Dis.44, 904–910 (2007).
  • Heikkinen T, Osterback R, Peltola V, Jartti T, Vainionpää R. Human metapneumovirus infections in children. Emerg. Infect. Dis.14, 101–106 (2008).
  • Smuts H, Workman L, Zar HJ. Role of human metapneumovirus, human coronavirus NL63 and human bocavirus in infants and young children with acute wheezing. J. Med. Virol.80, 906–912 (2008).
  • Montalbano MM, Lemanske RF Jr. Infections and asthma in children. Curr. Opin. Pediatr.14, 334–337 (2002).
  • Blasi F, Johnston SL. The role of antibiotics in asthma. Int. J. Antimicrob. Agents29, 485–493 (2007).
  • Nisar N, Guleria R, Kumar S, Chawla TC, Biswas NR. Mycoplasma pneumoniae and its role in asthma. Postgrad. Med. J.83, 100–104 (2007).
  • Korppi M, Paldanius M, Hyvärinen A, Nevalainen A.. Simkania negevensis and newly diagnosed asthma: a case–control study in 1- to 6-year-old children. Respirology11, 80–83 (2006).
  • McIntosh K, Ellis EF, Hoffman LS, Lybass TG, Eller JJ, Fulginiti VA. The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J. Pediatr.82, 578–590 (1973).
  • Weinberger M. Respiratory infections and asthma: current treatment strategies. Drug Discov. Today9, 831–837 (2004).
  • Lai L, Hopp RJ, Lusk RP. Pediatric chronic sinusitis and asthma: a review. J. Asthma43, 719–725 (2006).
  • Lusk R. Pediatric chronic rhinosinusitis. Curr. Opin. Otolaryngol. Head Neck Surg.14, 393–396 (2006).
  • Henderson M, Rubin E. Misuse of antimicrobials in children with asthma and bronchiolitis: a review. Pediatr. Infect. Dis. J.20, 214–215 (2001).
  • Gilberg K, Laouri M, Wade S, Isonaka S. Analysis of medication use patterns: apparent overuse of antibiotics and underuse of prescription drugs for asthma, depression, and CHF. J. Manag. Care Pharm.9, 232–237 (2003).
  • Stallworth LE, Fick DM, Ownby DR, Waller JL. Antibiotic use in children who have asthma: results of retrospective database analysis. J. Manag. Care Pharm.11, 657–662 (2005).
  • Kozyrskyj AL, Dahl ME, Ungar WJ, Becker AB, Law BJ. Antibiotic treatment of wheezing in children with asthma: what is the practice? Pediatrics117, e1104–e1110 (2006).
  • Giamarellos-Bourboulis EJ. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators. Int. J. Antimicrob. Agents31, 12–20 (2008).
  • Montalbano MM, Lemanske RF Jr. Infections and asthma in children. Curr. Opin. Pediatr.14, 334–337 (2002).
  • Korppi M, Kotaniemi-Syrjänen A, Waris M, Vainionpää R, Reijonen TM. Rhinovirus-associated wheezing in infancy: comparison with respiratory syncytial virus bronchiolitis. Pediatr. Infect. Dis. J.23, 995–999 (2004).
  • Kotaniemi-Syrjänen A, Vainionpää R, Reijonen TM, Waris M, Korhonen K, Korppi M. Rhinovirus-induced wheezing in infancy – the first sign of childhood asthma? J. Allergy Clin. Immunol.111, 66–71 (2003).
  • Hyvärinen MK, Kotaniemi-Syrjänen A, Reijonen TM, Korhonen K, Korppi MO. Teenage asthma after severe early childhood wheezing: an 11-year prospective follow-up. Pediatr. Pulmonol.40, 316–323 (2005).
  • Hyvärinen MK, Kotaniemi-Syrjänen A, Reijonen TM, Korhonen K, Korppi MO. Lung function and bronchial hyper-responsiveness 11 years after hospitalization for bronchiolitis. Acta Paediatr.96, 1464–1469 (2007).
  • Jackson DJ, Gangnon RE, Evans MD et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am. J. Respir. Crit. Care Med.178, 667–672 (2008).
  • Piippo-Savolainen E, Korppi M. Wheezy babies – wheezy adults? Review on long-term outcome until adulthood after early childhood wheezing. Acta Paediatr.97, 5–11 (2008).
  • Lemanske RF. Viral infections and asthma inception. J. Allergy Clin. Immunol.114, 1023–1026 (2004).
  • Calvo C, García-García ML, Blanco C et al. Multiple simultaneous viral infections in infants with acute respiratory tract infections in Spain. J. Clin. Virol.42, 268–272 (2008).
  • Allander T. Human bocavirus. J. Clin. Virol.41, 29–33 (2008).
  • Chung JY, Han TH, Kim SW, Kim CK, Hwang ES. Detection of viruses identified recently in children with acute wheezing. J. Med. Virol.79, 1238–1243 (2007).
  • Chieochansin T, Samransamruajkit R, Chutinimitkul S et al. Human bocavirus (HBoV) in Thailand: clinical manifestations in a hospitalized pediatric patient and molecular virus characterization. J. Infect.56, 137–142 (2008).
  • Kantola K, Hedman L, Allander T et al. Serodiagnosis of human bocavirus infection. Clin. Infect. Dis.46, 540–546 (2008).
  • Miller EK, Griffin MR, Edwards KM et al. Influenza burden for children with asthma. Pediatrics121, 1–8 (2008).
  • Korppi M, Leinonen M, Koskela M, Mäkelä PH, Saikku P, Launiala K. Bacterial infection in under school age children with expiratory difficulty. Pediatr. Pulmonol.10, 254–259 (1991).
  • Lehtinen P, Jartti T, Virkki R, Vuorinen T, Leinonen M, Peltola V. Bacterial coinfections in children with viral wheezing. Eur. J. Clin. Microbiol. Infect. Dis.25, 463–469 (2006).
  • Heiskanen-Kosma T, Korppi M, Jokinen C et al. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr. Infect. Dis. J.17, 986–991 (1998).
  • Juvén T, Mertsola J, Waris M et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr. Infect. Dis. J.19, 293–298 (2000).
  • Talbot TR, Hartert TV, Mitchel E et al. Asthma as a risk factor for invasive pneumococcal disease. N. Engl. J. Med.352, 2082–2090 (2005).
  • Chang AB, Redding GJ, Everard ML. Chronic wet cough: protracted bronchitis, chronic suppurative lung disease and bronchiectasis. Pediatr. Pulmonol.43, 519–531 (2008).
  • Erkan L, Uzun O, Findik S, Katar D, Sanic A, Atici AG. Role of bacteria in acute exacerbations of chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis.3, 463–467 (2008).
  • Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology9, 109–114 (2004).
  • Freymuth F, Vabret A, Brouard J et al. Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J. Clin. Virol.13, 131–139 (1999).
  • Esposito S, Blasi F, Arosio C et al. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. Eur. Respir. J.16, 1142–1146 (2000).
  • Thumerelle C, Deschildre A, Bouquillon C et al. Role of viruses and atypical bacteria in exacerbations of asthma in hospitalized children: a prospective study in the Nord-Pas de Calais region (France). Pediatr. Pulmonol.35, 75–82 (2003).
  • Biscardi S, Lorrot M, Marc E et al.Mycoplasma pneumoniae and asthma in children. Clin. Infect. Dis.38, 1341–1346 (2004).
  • Dallo SF, Baseman JB. Intracellular DNA replication and long-term survival of pathogenic mycoplasmas. Microb. Pathog.29, 301–309 (2000).
  • Cunningham AF, Johnston SL, Julious SA, Lampe FC, Ward ME. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur. Respir. J.11, 345–349 (1998).
  • Kjaer BB, Jensen JS, Nielsen KG et al. Lung function and bronchial responsiveness after Mycoplasma pneumoniae infection in early childhood. Pediatr. Pulmonol.43, 567–575 (2008).
  • Korppi M, Leinonen M, Saikku P. Chlamydial infection and reactive airway disease. Arch. Pediatr. Adolesc. Med.149, 341–342 (1995).
  • Emre U, Roblin PM, Gelling M et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch. Pediatr. Adolesc. Med.148, 727–732 (1994).
  • Teig N, Anders A, Schmidt C, Rieger C, Gatermann S. Chlamydophila pneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases. Thorax60, 962–966 (2005).
  • Sutherland ER, Martin RJ. Asthma and atypical bacterial infection. Chest132, 1962–1966 (2007).
  • Webley WC, Salva PS, Andrzejewski C et al. The bronchial lavage of pediatric patients with asthma contains infectious Chlamydia.Am. J. Respir. Crit. Care Med.171, 1083–1088 (2005).
  • Mills GD, Lindeman JA, Fawcett JP, Herbison GP, Sears MR. Chlamydia pneumoniae serological status is not associated with asthma in children or young adults. Int. J. Epidemiol.29, 280–284 (2000).
  • Korppi M, Paldanius M, Hyvarinen A, Nevalainen A, Husman T. Chlamydia pneumoniae and newly diagnosed asthma: a case–control study in 1 to 6-year-old children. Respirology9, 255–259 (2004).
  • Webley WC, Tilahun Y, Lay K et al. Occurrence of Chlamydia trachomatis and Chlamydia pneumoniae in paediatric respiratory infections. Eur. Respir. J.33, 360–367 (2009).
  • Chen CJ, Wu KG, Tang RB, Yuan HC, Soong WJ, Hwang BT. Characteristics of Chlamydia trachomatis infection in hospitalized infants with lower respiratory tract infection. J. Microbiol. Immunol. Infect.40, 255–259 (2007).
  • Ragunathan PL, Gray JW, Kenna AP, Lightfoot NF. No evidence of Chlamydia trachomatis infection in children with wheeze. Eur. J. Clin. Microbiol. Infect. Dis.14, 470–471 (1995).
  • Friedman MG, Dvoskin B, Kahane S. Infections with the chlamydia-like microorganism Simkania negevensis, a possible emerging pathogen. Microbes Infect.5, 1013–1021 (2003).
  • Yamaguchi T, Yamazaki T, Inoue M et al. Prevalence of antibodies against Simkania negevensis in a healthy Japanese population determined by the microimmunofluorescence test. FEMS Immunol. Med. Microbiol.43, 21–27 (2005).
  • Greenberg D, Banerji A, Friedman MG, Chiu CH, Kahane S. High rate of Simkania negevensis among Canadian inuit infants hospitalized with lower respiratory tract infections. Scand. J. Infect. Dis.35, 506–508 (2003).
  • Fasoli L, Paldanius M, Don M et al.Simkania negevensis in community-acquired pneumonia in Italian children. Scand. J. Infect. Dis.40, 269–272 (2008).
  • Heiskanen-Kosma T, Paldanius M, Korppi M. Simkania negevensis may be a true cause of community acquired pneumonia in children. Scand. J. Infect. Dis.40, 127–130 (2008).
  • Kumar S, Kohlhoff SA, Gelling M et al. Infection with Simkania negevensis in Brooklyn, New York. Pediatr. Infect. Dis. J.24, 989–992 (2005).
  • Sotir MJ, Cappozzo DL, Warshauer DM et al. A countywide outbreak of pertussis: initial transmission in a high school weight room with subsequent substantial impact on adolescents and adults. Arch. Pediatr. Adolesc. Med.162, 79–85 (2008).
  • de Greeff SC, Mooi FR, Schellekens JF, de Melker HE. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatr. Infect. Dis. J.27, 218–223 (2008).
  • Heininger U. Pertussis immunisation in adolescents and adults. Adv. Exp. Med. Biol.609, 72–97 (2008).
  • Ennis DP, Cassidy JP, Mahon BP. Prior Bordetella pertussis infection modulates allergen priming and the severity of airway pathology in a murine model of allergic asthma. Clin. Exp. Allergy34(9), 1488–1497 (2004).
  • Cruz AA, Popov T, Pawankar R et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy62(Suppl. 84), 1–41 (2007).
  • de Benedictis FM, Bush A. Rhinosinusitis and asthma: epiphenomenon or causal association? Chest115, 550–556 (1999).
  • Puhakka T, Mäkelä MJ, Alanen A et al. Sinusitis in the common cold. J. Allergy Clin. Immunol.102, 403–408 (1998).
  • Kristo A, Uhari M, Luotonen J et al. Paranasal sinus findings in children during respiratory infection evaluated with magnetic resonance imaging. Pediatrics11, e586–e589 (2003).
  • Kristo A, Alho OP, Luotonen J, Koivunen P, Tervonen O, Uhari M. Cross-sectional survey of paranasal sinus magnetic resonance imaging findings in school children. Acta Paediatr.92, 34–36 (2003).
  • Blomberg K, Alho OP, Ertama L et al. Acute sinusitis: Finnish clinical practice guidelines. Scand. J. Infect. Dis.37, 245–250 (2005).
  • O’Hara J, Jones NS. ‘Post-nasal drip syndrome’: most patients with purulent nasal secretions do not complain of chronic cough. Rhinology44, 270–273 (2006).
  • Marra F, Lynd L, Coombes M et al. Does antibiotic exposure during infancy lead to development of asthma?: a systematic review and metaanalysis. Chest129, 610–618 (2006).
  • Thomas M, Custovic A, Woodcock A, Morris J, Simpson A, Murray CS. Atopic wheezing and early life antibiotic exposure: a nested case–control study. Pediatr. Allergy Immunol.17, 184–188 (2006).
  • Kozyrskyj AL, Ernst P, Becker AB. Increased risk of childhood asthma from antibiotic use in early life. Chest131, 1753–1759 (2007).
  • Kusel MM, de Klerk N, Holt PG, Sly PD. Antibiotic use in the first year of life and risk of atopic disease in early childhood. Clin. Exp. Allergy38, 1921–1928 (2008).
  • Farrell DJ, Jenkins SG, Brown SD, Patel M, Lavin BS, Klugman KP. Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerg. Infect. Dis.11, 851–858 (2005).
  • Pennie RA. Pneumococcal vaccine. Can. Fam. Physician45, 2271–2277 (1999).
  • Kozyrskyj AL, Carrie AG, Mazowita GB, Lix LM, Klassen TP, Law BJ. Decrease in antibiotic use among children in the 1990s: not all antibiotics, not all children. Can. Med. Ass. J.171, 133–138 (2004).
  • Black PN. Antibiotics for the treatment of asthma. Curr. Opin. Pharmacol.7, 266–271 (2007).
  • Johnston SL. Macrolide antibiotics and asthma treatment. J. Allergy Clin. Immunol.117, 1233–1236 (2006).
  • Johnston SL, Blasi F, Black PN, Martin RJ, Farrell DJ, Nieman RB. The effect of telithromycin in acute exacerbations of asthma. N. Engl. J. Med.354, 1589–1600 (2006).
  • Shinkai M, Rubin BK. Macrolides and airway inflammation in children. Paediatr. Respir. Rev.6, 227–235 (2005).
  • Strunk RC, Bacharier LB, Phillips BR et al. Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study. J. Allergy Clin. Immunol.122, 1138–1144 (2008).
  • Richeldi L, Ferrara G, Fabbri LM, Lasserson TJ, Gibson PG. Macrolides for chronic asthma. Cochrane Database Syst. Rev.19(4), CD002997 (2005).
  • Esposito S, Bosis S, Faelli N et al. Role of atypical bacteria and azithromycin therapy for children with recurrent respiratory tract infections. Pediatr. Infect. Dis. J.24, 438–444 (2005).
  • Piacentini GL, Peroni DG, Bodini A et al. Azithromycin reduces bronchial hyperresponsiveness and neutrophilic airway inflammation in asthmatic children: a preliminary report. Allergy Asthma Proc.28, 194–198 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.